Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin
Recruiting
Phase N/A Results N/ASummary of Purpose
The purpose of the Stroke AF study is to compare the incidence of atrial fibrillation (AF) through 12 months between continuous cardiac rhythm monitoring with the Reveal LINQ™ Insertable Cardiac Monitor (ICM) (continuous monitoring arm) and standard of care (SoC) medical treatment (control arm) in subjects with a recent ischemic stroke of presumed known origin.
Read More →Trial Milestones
The following dates are available for this trial. Trial information last updated on 22 March 2018.
1 Mar 2016 | 2 Mar 2016 | 1 Nov 2018 | 1 Feb 2021 | 1 Mar 2018 | Unavailable |
Start Date | First Received | 1st Completion | Completion | Verification | Results |
---|
Trial Basics
Interventions
Conditions
Sponsors
Trial Design
- Allocation: Randomized
- Masking: Open Label
- Purpose: Diagnostic
- Intervention: Parallel Assignment
Contacts
- Caroline Churchill, PhD
caroline.c.churchill@medtronic.com 763-526-1029
- Medtronic INC
1-800-328-2518
- Kathleen Graham, BS, CCRP
kathleen.a.graham@medtronic.com 763-526-7835
View Trial Locations
Recruitment
- Enrollment: 496
- Gender: All
- Minimum Age: 50 Years
- Accepts Healthy Volunteers: No
- 39 locations, 1 country
Principal Investigators
- Lee Schwamm, MD
Massachusetts General Hospital
- Richard Bernstein, PhD/MD
Northwestern